1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Genetic Pathways Leading to Fatty Liver and Atherogenic DyslipidemiaDigestive System Diseases, Insulin Resistance, Nutritional and Metabolic Diseases, fatty liver disease, glucose metabolism disease, hyperinsulinism, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver diseaseEnrolling by invitationNot stated2023-09-22NCT04209816